3 Reasons to Sell G and 1 Stock to Buy Instead
Even during a down period for the markets, Genpact has gone against the grain, climbing to $50.06. Its shares have yielded a 27.5% return over the last six months, beating the S&P 500 by 29.2%. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.